ArticleImmunology2007

Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.

Marina Zafranskaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.